ESR1 and breast carcinoma: In vitro experiments have demonstrated that tamoxifen induces high HPSE expression in breast cancer cells by increasing amplified in breast cancer 1 (AIB1) levels, which may partially explain the failure of tamoxifen treatments in ER-positive patients [18].